Edward J. Dulac III - EVP, Chief Financial Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Edward J. Dulac III since 11/5/2023

Holdings reported by Edward J. Dulac III for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 66.3K $1.52M $22.93 Jul 22, 2024 Direct
Stock Option (right to buy) 96.2K Jul 22, 2024 Direct Common Stock

Transactions reported by Edward J. Dulac III for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.